Share Price | Triochem Products Ltd Stock Analysis & Recommendation

Q: What does Triochem Product do?

Overview:Triochem Products Ltd is engaged in the manufacturing and exporting of pharmaceutical products, APIs, and chemicals, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.History:The company was incorporated on January 17, 1972. The latest quarterly results reported are for March 2025, during which the company recorded a net profit.Financial Snapshot:Most recent Net Sales: N/AMost recent Net Profit: -4 Cr (Quarterly Results - Mar 2025)Market-cap value: INR Cr (Micro Cap)Key Metrics:Industry P/E: N/ADividend Yield: 0.00%Debt Equity: 0.00Return on Equity: 0.00%Price to Book: 0.00Contact Details:Address: Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001Phone: 91-22-22663150Email: investor@triochemproducts.comWebsite: http://www.triochemproducts.com

Q: Who are the top shareholders of the Triochem Product?

The top shareholders of Triochem Product include the promoters, with Rajesh Ramu Deora holding the largest share at 14.69%. Additionally, Ambernath Plasto Packaging Private Limited is the highest public shareholder, owning 4.9%. Individual investors collectively hold 15.53% of the shares. There are currently no mutual funds or foreign institutional investors holding shares in the company.

Q: Why is Triochem Products Ltd falling/rising?

As of 05-May, the stock price of Triochem Products Ltd is currently at 17.40, with no change from the previous trading session (0.00%). The stock has not experienced any price movement over the past week, month, or year, indicating a stagnation in its performance. In comparison to the benchmark Sensex, which has shown a slight increase of 0.17% over the past week and a more significant gain of 5.04% over the past month, Triochem Products Ltd has underperformed, with a 0.00% change in the same periods.The stock's performance today is particularly concerning, as it has underperformed its sector by a substantial margin of -99.34%. Additionally, the stock has not traded on five out of the last twenty days, suggesting erratic trading behavior. It is also trading below its moving averages across various time frames (5 day, 20 day, 50 day, 100 day, and 200 day), which typically indicates a bearish trend. Furthermore, while the BSE Small Cap index has gained by 1.42%, Triochem Products Ltd's stagnant price and lack of movement suggest that it is not benefiting from the overall market conditions. The liquidity of the stock is noted to be adequate for trading, but the overall performance metrics indicate that the stock is not rising and is instead reflecting a lack of investor interest and confidence.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

68.65%

When is the next results date for Triochem Product?

16-May-2025

No Upcoming Board Meetings

Who are in the management team of Triochem Product?

16-Jul-2025

As of March 2023, the management team of Triochem Product includes Ramu S Deora (CEO), Sunil S Jhunjhunwala (Independent Director), S S Sharma (Director), Girish Kumar Pungalia (Independent Director), Rajesh Ramu Deora (Director), Ureca Shirish Shirole (Company Secretary), and Grace R. Deora (Non-Executive Director). Each member contributes to the company's governance and operations.

View full answer

What does Triochem Product do?

17-Jul-2025

Triochem Products Ltd manufactures and exports pharmaceutical products, APIs, and chemicals, operating as a Micro Cap company. As of March 2025, it reported a net profit of -4 Cr.

View full answer

Who are the top shareholders of the Triochem Product?

17-Jul-2025

The top shareholders of Triochem Product include Rajesh Ramu Deora with 14.69%, Ambernath Plasto Packaging Private Limited at 4.9%, and individual investors holding a combined 15.53%. There are no mutual funds or foreign institutional investors currently involved.

View full answer

Why is Triochem Products Ltd falling/rising?

06-May-2026

As of 05-May, the stock price of Triochem Products Ltd is stagnant at 17.40, showing no change and underperforming compared to the Sensex and its sector. The stock has not traded on five of the last twenty days and is below its moving averages, indicating a bearish trend and lack of investor interest.

View full answer

Which are the latest news on Triochem Product?

06-May-2026

No latest news for Triochem Product found.

Compare Triochem Product with Similar Stocks

Shyama Computro.Fabino Enter Brawn Biotech

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR Cr (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

0 Cr

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

16-Apr-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No.	Particulars	Details
1	Name of Company	Triochem Products Ltd
2	CIN NO.	L24249MH1972PLC015544
3	Report filed for FY	2025-2026
Details of the Current block (all figures in Rs crore):
4	2 - year block period (Specify financial years)*	FY2025-20262026-2027
5	Incremental borrowing done in FY (T)(a)	0.00
6	Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)	0.00
7	Actual borrowing done through debt securities in FY (T)(c)	0.00
8	Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)	0
8	Quantum of (d) which has been met from (c)(e)*	0
9	Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*	0

Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)	FY2025-20262026-2027
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#	0.00

Name of the Company Secretary :-	Ureca Deolekar
Designation :-	Company Secretary and Compliance Officer
Name of the Chief Financial Officer :-	Puran Jaykisan Parmar
Designation : -	Chief Financial Officer

Date: 16/04/2026

Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions

16-Apr-2026 | Source : BSE

Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks / financial institutions

Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities

16-Apr-2026 | Source : BSE

Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Ramu Deora (14.69%)

Highest Public shareholder

Triochem Laboratories Private Limited (4.9%)

Individual Investors Holdings

15.53%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 31.58% vs -533.33% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.38",
          "val2": "-0.42",
          "chgp": "9.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.13",
          "val2": "-0.19",
          "chgp": "31.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.78",
          "val2": "-0.60",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "-0.12",
          "chgp": "-83.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.16",
          "val2": "-1.19",
          "chgp": "2.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.35",
          "val2": "-0.03",
          "chgp": "-1,066.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 60.40% vs -13.48% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.22",
          "val2": "-1.11",
          "chgp": "-9.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.16",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.40",
          "val2": "-1.01",
          "chgp": "60.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.38

-0.42

9.52%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.13

-0.19

31.58%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 31.58% vs -533.33% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.78

-0.60

-30.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.22

-0.12

-83.33%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.16

-1.19

2.52%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.35

-0.03

-1,066.67%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.22

-1.11

-9.91%

Interest

0.00

Exceptional Items

0.00

-1.16

100.00%

Standalone Net Profit

-0.40

-1.01

60.40%

Operating Profit Margin (Excl OI)

0.00%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 60.40% vs -13.48% in Mar 2024

All Annual Results

Company CV

About Triochem Products Ltd

Triochem Products Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Triochem Products Ltd was incorporated in the year January 17, 1972. The Company is engaged in the business of manufacturer and exporter of pharmaceuticals products, API and chemicals.

Company Coordinates

Company Details

Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001

Tel: 91-22-22663150

http://www.triochemproducts.com

investor@triochemproducts.com

Registrar Details

Sharex (India) Pvt Ltd , Unit No.1, Luthra Ind.Premises Andheri Kurla Road, Safed Pool , Mumbai